kidney stones and glp-1 weight-loss drugs might help protect kidneys GLP-1 receptor agonists and gallbladder

Reason #4: We dont know enough yet This is perhaps the most honest reason: the absence of data isnt the same as data showing safety

Notably, in high-quality large RCTs, tirzepatide demonstrated greater effectiveness than GLP-1R mono agonists in reducing serum glucose, fat mass, and body weight

Soon Raufman was walking out of Pisanos lab with an assortment of powdered venom samples: snake venoms, wasp venoms, bee venoms, and venom from a strange lizard known as the Gila monster

Pharmacology of GLP-1-based therapies

A large cohort study in The Lancet Diabetes & Endocrinology found that the diabetes risk a White adult faces at a BMI of 30 shows up in South Asian adults at a BMI as low as 23.9

Plaintiffs allege that manufacturers failed to adequately warn about the risk of vision loss associated with these medications